Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
Amgen
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
University of Florida
PedAL BCU, LLC
AstraZeneca
Novartis
Eastern Cooperative Oncology Group
City of Hope Medical Center
Sumitomo Pharma America, Inc.
Syndax Pharmaceuticals
University of Chicago
AstraZeneca
Chinese PLA General Hospital
National Institutes of Health Clinical Center (CC)
Beijing GoBroad Hospital
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
Servier
Ossium Health, Inc.
City of Hope Medical Center
MSD R&D (China) Co., Ltd.
University of Alberta
National Research Center for Hematology, Russia
BIOHENG THERAPEUTICS US LLC
Novartis
Memorial Sloan Kettering Cancer Center
Stanford University
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Sanofi
St. Jude Children's Research Hospital
Bambino Gesù Hospital and Research Institute
Bambino Gesù Hospital and Research Institute
Beijing GoBroad Hospital
Beijing GoBroad Hospital
St. Jude Children's Research Hospital
Kura Oncology, Inc.
Abramson Cancer Center at Penn Medicine
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Seattle Children's Hospital